Spots Global Cancer Trial Database for bisphosphonates
Every month we try and update this database with for bisphosphonates cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates | NCT00104650 | Bone Metastases... Bone Metastases... Bone Metastases... | AMG 162 180 mg ... IV Bisphosphona... AMG 162- 180 mg... | 18 Years - | Amgen | |
| First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade | NCT01215344 | Multiple Myelom... | VELCADE Lenalidomide Dexamethasone DVT prophylaxis Bisphosphonates Liposomal doxor... Dexamethasone | 18 Years - 70 Years | Vanderbilt-Ingram Cancer Center | |
| A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) | NCT00172042 | Non-Small-Cell ... | Zoledronic acid... | 18 Years - | Novartis | |
| Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer | NCT00391690 | Prostate Cancer | Zoledronic acid | 18 Years - | Novartis | |
| Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer | NCT00391690 | Prostate Cancer | Zoledronic acid | 18 Years - | Novartis | |
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer | NCT00859703 | Breast Cancer Menopause Osteopenia | Risedronate Placebo | 18 Years - | Hospices Civils de Lyon | |
| Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma | NCT00691236 | Osteosarcoma | Zoledronic acid Standard chemot... | 18 Years - 65 Years | Tata Memorial Hospital | |
| First Autologous Transplant on Minimal Residual Disease Markers in Previously Untreated Myeloma Undergoing Initial Treatment With Velcade | NCT01215344 | Multiple Myelom... | VELCADE Lenalidomide Dexamethasone DVT prophylaxis Bisphosphonates Liposomal doxor... Dexamethasone | 18 Years - 70 Years | Vanderbilt-Ingram Cancer Center | |
| Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates | NCT00104650 | Bone Metastases... Bone Metastases... Bone Metastases... | AMG 162 180 mg ... IV Bisphosphona... AMG 162- 180 mg... | 18 Years - | Amgen | |
| A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) | NCT00172042 | Non-Small-Cell ... | Zoledronic acid... | 18 Years - | Novartis | |
| Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma | NCT00216151 | Multiple Myelom... | Zoledronic Acid | 18 Years - | Hoosier Cancer Research Network | |
| Arimidex Bone Mass Index and Oral Bisphosphonates | NCT00809484 | Breast Cancer Bone Density | 18 Years - 80 Years | Hellenic Breast Surgeons Society | ||
| Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction | NCT02661139 | Head and Neck C... Osteonecrosis Osteoradionecro... | - | AZ Sint-Jan AV | ||
| Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma | NCT00691236 | Osteosarcoma | Zoledronic acid Standard chemot... | 18 Years - 65 Years | Tata Memorial Hospital | |
| Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction | NCT02661139 | Head and Neck C... Osteonecrosis Osteoradionecro... | - | AZ Sint-Jan AV | ||
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer | NCT00859703 | Breast Cancer Menopause Osteopenia | Risedronate Placebo | 18 Years - | Hospices Civils de Lyon | |
| Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | NCT00334139 | Prostate Cancer Breast Cancer Bone Metastasis | Zoledronic Acid | 18 Years - | Novartis | |
| Higher Frequency Zoledronic Acid in the Treatment of Multiple Myeloma | NCT00263484 | Multiple Myelom... | dexamethasone thalidomide zoledronic acid | 21 Years - | Gleneagles Hospital | |
| Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy | NCT00050011 | Breast Neoplasm... Osteoporosis | Zoledronic Acid Letrozole | 18 Years - 85 Years | Novartis | |
| Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer | NCT00321620 | Bone Metastases | zoledronic acid denosumab | 18 Years - | Amgen | |
| Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET) | NCT04720391 | Bone Metastases Neuroendocrine ... | - | European Institute of Oncology | ||
| A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients | NCT03543072 | Breast Cancer | Bisphosphonates | 18 Years - | Sun Yat-sen University | |
| Arimidex Bone Mass Index and Oral Bisphosphonates | NCT00809484 | Breast Cancer Bone Density | 18 Years - 80 Years | Hellenic Breast Surgeons Society | ||
| Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium | NCT00896454 | Breast Cancer Hypercalcemia o... Colon Cancer Endocrine Cance... Head and Neck C... Kidney Cancer Lung Cancer Lymphoma Metastatic Canc... Multiple Myelom... Parathyroid Neo... Renal Cancer Thyroid Cancer Hodgkin's Lymph... Non-Hodgkin's L... Non-Small Cell ... | denosumab | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
